Subject Index

A

Abacavir, 9 Acute coronary syndrome, 106,111,117,118,

124, 195, 211 Adipocytokines, 37 Adiponectin, 37-39, 41, 44, 46, 47 Antiarrhythmics, 235, 238, 240 Antibiotics, 27, 209 Anticoagulants, 119,138, 152, 174, 237-239 Apoptosis, 12, 25, 26, 46-48, 57, 78, 117, 158,

159, 185

Arrhythmias, 26, 27, 78, 85, 95, 134, 138, 185, 203, 204, 208, 209, 212, 223

Aspergillus fumigatus, 24, 61, 89,193, 204 Atherosclerosis, 16, 27, 40-42, 55, 69, 77, 86,

114, 116-118, 123, 124, 134, 137, 138, 141, 147, 149-151, 153, 154, 170, 171, 181, 185, 187

B

Beraprost, 162, 166 Bosentan, 162, 166 Bradycardia, 24, 46, 208

C

Calcium channel blockers, 27, 163, 211 Candida albicans, 56, 57, 61, 63, 65, 89, 193,

204

Cardiac magnetic resonance, 85 Cardiomyopathy, 16-23, 26, 27, 55, 57, 75, 78,

79, 85, 89, 90, 92-96, 106, 114, 134, 135, 152, 181-184, 195, 196, 203, 208-210, 121 autoimmunity, 19 causes of, 19 echocardiographic classification, 17 encephalopathy, 21, 22

Cardiovascular disease HIV-associated, prevention, 111, 118, 213

Cardiovascular

monitoring, 229

risk, 10, 96, 111, 116, 118, 124, 137, 147-

149, 185, 213, 229

CD4 + T-cell lymphocytes 1, 2

Cell adhesion molecules, 26, 57

Cell saver, 199

Cerebrovascular disease, 101, 131, 132, 138,

141

Children

cardiovascular malformations, 15, 186­187

HIV-infected, 5, 123, 141, 174, 181-186 Chlamydia trachomatis, 206

Coagulative disorders, 16, 169, 172, 175 Cocaine abuse, 145

Coccidioides immitis, 26, 89 Conduction tissue, 58

Coronary artery bypass grafting, 192,195,196 Coronary artery disease, 75, 86, 94, 95, 101,

111, 115, 192, 203, 209, 211, 217 aspirin, 119 lesions, 195 pathophysiology, 111 prognosis, 111 treatment, 111

Coronary heart disease, 16, 99, 100, 102, 106, 111,119, 210,213,215

cholesterol, 107, 116 epidemiology, 99, 111 outcome, 106

Coronary vessels, pathology of, 65

Cryptococcus neoformans, 56, 63, 59, 204, 206 Cytomegalovirus, 3, 16, 20, 22, 26, 56, 57, 62,

63, 65, 72, 79, 86, 89, 93, 133-135, 139, 140,

153, 173, 175, 183,184, 193, 204, 206, 208

D

Delavirdine, 27, 238-239

Diabetes mellitus, 28, 34, 107, 116, 118, 120, 122-124, 137

Dilated cardiomyopathy, 16-18, 20, 23, 26, 55,

57, 78, 79, 90, 92, 93, 96, 135, 152, 181, 196, 203, 208, 210

survival rate, 18, 20

Drugs,

anti-infective, 27

antilipidemic, 217

antiretroviral, 4, 10, 48, 79, 99, 101,106, 107, 184, 209, 213

interactions, 235, 238 Dyslipidemia, 27, 33, 42, 44, 111, 112, 116­117, 119-122, 134, 137, 184, 217

E

Eccentric hypertrophy, 55 Echocardiography, 15,24,75, 76, 78-82, 89,115, 161, 183, 186, 187, 205, 206, 211

Efavirenz, 9, 27, 45, 122, 239 Electrocardiogram, 160, 204

Emergencies, cardiac, 203, 204 Endocarditis, 19, 24, 25, 57, 60-62, 75, 81, 85,

93, 134, 135, 150, 184, 191, 193, 194, 196, 200, 203-206, 208, 210, 211, 223

infective, 24, 25,57, 60,61, 81, 85,184,193, 203, 205, 206,208,210,211

Endocardium, pathology, 60 Endothelial-derived proteins, 170

Endothelial dysfunction, 16, 25,134,137,185 Epoprostenol, 162, 166, 211

F

Fat alterations, 45

G

Glucose metabolism, 43, 45

H

HAART, 11, 4-10, 15-18, 21, 23-26, 28, 29, 42, 44, 45, 47-49, 57-60, 62, 65, 75-80, 82, 85-87, 92, 96, 102, 111, 114, 116, 118, 119, 121, 123, 124,131,132,136-138,147,150,162,163,169­173,175-177,191-194,204,206,211, 213,217, 218, 229-232

coagulative disorders, 16, 169, 172, 175 coronary heart disease, 16,99-100,102,106, 111,119,210,213,215

dyslipidemia, 42, 44, 116, 119 ischemic accident, 132 lipodystrophy syndrome, 27, 33, 44-48,

77, 86, 99,116, 123, 147, 169, 184, 213 metabolic disorders, 28, 44, 100, 111, 117 metabolic syndrome, 29, 48, 169-171 neurological complications, 131 pulmonary hypertension, 59, 79 thrombocytopenia, 176

HACEK bacteria, 61

Haemophilus influenzae, 24, 61, 81 Heart transplantation, 124, 196

Hepatitis B, 7, 149-150

Hepatitis C, 99, 147

Highly active antiretroviral therapy,

(see HAART)

Histoplasma capsulatum, 26, 204

HIV

infection, 25, 96, 181

HOMA index, 35

Hypertension, «-adrenoreceptors, 158,159 diagnostic tests, 160 pathogenesis, 157, 161 pulmonary, 17, 59, 79, 85, 157-166, 203, 211, 213

systemic, 16, 80, 123 treatment, 161

I

Insulin,

resistance, 16, 27, 28, 33, 35, 37, 38, 39, 40, 41,42,44,46,47,99,116,123,134,137,169, 184, 213, 217

Interleukin-6, 19, 38, 39, 116, 158, 159

Intracerebral hemorrhages, 132, 139, 141 Ischemic heart disease, 37, 55, 57, 85, 86, 105 Ischemic stroke, 131, 132, 133, 134, 135, 138, 139, 141

K

Kaposi’s sarcoma, 3, 16, 17, 25, 26, 28, 55, 58, 59, 63, 82, 86, 139, 173, 184, 193, 196, 197, 203, 204, 206

Kawasaki-like syndrome, 25, 150

L

Lactic acidosis, 22, 27,123, 200

Leptin, 36, 37, 39, 47 Lipid-lowering agents, 121, 123, 149 Lipoatrophy

HAART-associated, 6, 29, 57

Listeria monocytogenes, 206

Lymphomas, 17, 28, 58, 64, 82

M

Metabolic syndrome, 16, 29, 33, 34, 35, 39, 40, 41, 42, 44, 45, 48, 49, 123, 169

HAART-associated, 169, 170, 171, 211 in non-HIV-infected, 33, 34

Metformin, 123, 169, 217

Mycobacteria, 16, 63, 193

Myocardial infarction, 26, 39, 57, 72, 85, 86, 93, 96, 99, 102, 103, 104, 111, 112, 113,114, 116, 117, 118, 119, 123, 184, 195, 203, 204, 205, 209, 210, 211

Myocarditis, 17, 19, 26, 55, 56, 57, 58, 61, 62, 75, 78, 79, 85, 89, 90, 91, 92, 93, 94, 95, 96, 134, 135, 183, 186, 203, 204, 205, 208, 209, 210, 223

incidence, 18

N

Neurological complications, 131 Nevirapine, 27,45, 48, 122, 238, 239 Nocardia, 16, 63, 193, 204, 206

Nutritional deficiencies, 15,21, 85, 89,181,184

O

Opportunistic infections, 1, 3, 4, 5, 6, 10, 15, 18, 25, 26, 28, 58, 59, 60, 72, 75, 77, 81, 85, 131, 134, 135, 136, 139, 160, 173, 174, 175, 181, 191, 192, 193, 203, 204, 206, 209, 213

P

Pericardial effusion, 16, 18, 23, 55, 59, 61, 62, 63, 64, 75, 76, 77, 78, 82, 86, 87, 90, 93, 184, 192, 193, 204, 206, 207, 208, 211

in children, 95

Pericardial tamponade, 23, 82, 192, 203 Pericarditis, 62, 63, 77,193, 204, 205, 206, 207, 208, 210, 223

Pericardium, pathology, 62

Peripheral arterial disease, 28, 29, 65, 147 Peripheral vessels, pathology of, 58, 65 Physical exercise, 216, 217

Plasminogen activator inhibitor I, 34, 39, 137, 169, 170, 229

Pneumocystis jiroveci, 3, 149

Primary angitis, 136

Primary prevention, 119, 120

in cardiovascular disease, 229

Protease inhibitors, 5, 16, 27, 28, 33, 57, 86, 99, 111,116,117,120,121,122,123,124,131, 134,148,149,163,169,170,171,172,185, 195, 203, 204, 216, 217, 235

R

Rhodococcus equi, 3, 206

Risk, cardiovascular, 10, 11, 96, 111, 116, 118, 123, 124, 137, 138, 147, 148, 149, 169, 184, 185, 213, 229

Ritonavir, 8, 27, 120, 121, 122, 124, 139, 140, 173, 177, 235, 236, 237

S

Sildenafil, 27, 163, 166

Simian immunodeficiency virus, 19, 72 Staphylococcus aureus, 24, 61, 63, 81,193, 203,

206

Statins, 27, 120, 121, 216, 217, 229, 236, 238 Streptococcus pneumoniae, 24, 61, 193 Surgery, 75, 123, 191, 192, 197, 198, 199, 200, 206, 211

cardiac, 191, 192, 193, 195, 196, 197, 198, 200, 201

valvular, 193, 194, 195, 196, 200

T

Tachycardia, 160, 209, 210 supraventricular, 209 ventricular, 27, 95, 209, 210

Tenofovir, 9, 27, 45, 122

Thrombocytopenia, 152, 175, 176, 210

Thrombosis, 39, 65, 66, 85, 117, 124, 140, 150, 151, 152, 158, 169, 172, 174, 175,184, 217 cerebral venous, 140, 172 venous, 39, 65, 172, 174

Thrombotic thrombocytopenic purpura, 175 Toxoplasma gondii, 16, 26, 56, 89, 149, 183, 206 Transfusion, 198, 199, 200

Transient ischemic accidents, 132

Transient neurological deficits, 133 Transmission risk, 200

Trypanosoma cruzi, 26

Tumor necrosis factor-α, 19, 38, 69, 80, 116, 158, 159

Tumors,

AIDS-related, 17, 28, 85 cardiac, 82, 95, 96, 197

V

Vascular alterations, 72

Vasculitic syndromes, 147, 149

Vasculitis, 16, 25, 65, 85, 134, 136, 138, 139, 140,141, 149, 152, 153, 186

Ventricular hypertrophy, 59, 203

von Willebrand’s factor, 72, 170, 171, 172

Z

Zidovudine (AZT), 9, 22, 23, 27, 45, 46, 47, 48, 79, 81, 89, 150, 176, 183, 184, 187, 204, 238